Paydirt
JM
Insider

Jeffrey A Meckler

Director

Jeffrey A Meckler (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $1.3M of TVTX (18,800 sh across 3 lots, as filed), executed Sep 10.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.6M
shares × price, as filed
Last traded
Sep 10
Filed Sep 11

Median ADV $123.0M across their filed names

Open performance
Volume by month
$1.3M$633K$0Oct 2024Apr 2025Oct 2025Apr 2026May 2026 · sells $360KSep 2026 · sells $1.3M
Buys $0 Sells $1.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
TVTX Travere Therapeutics, Inc. TVTX · 0 buys · 3 sells 3 filings
Recent filings
TVTXSALE Travere Therapeutics, Inc. View filing → $1.3M
18,800 sh across 3 lots
Exec Sep 10
Filed Sep 11 · 4:05 PM ET
TVTXSALE Travere Therapeutics, Inc. View filing → $360K
8,000 sh × $45.00
Exec May 4
Filed May 6 · 5:30 PM ET
TVTXSALE Travere Therapeutics, Inc. View filing → $562K
40,000 sh × $14.06
Exec Sep 30 2024
Filed Sep 30 2024 · 5:30 PM ET